BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29899868)

  • 41. Clinical Impact of Genomic Information in Pediatric Leukemia.
    Lalonde E; Wertheim G; Li MM
    Front Pediatr; 2017; 5():263. PubMed ID: 29312903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacogenomic Profiling of Pediatric Acute Myeloid Leukemia to Identify Therapeutic Vulnerabilities and Inform Functional Precision Medicine.
    Wang H; Chan KYY; Cheng CK; Ng MHL; Lee PY; Cheng FWT; Lam GKS; Chow TW; Ha SY; Chiang AKS; Leung WH; Leung AYH; Wang CC; Zhang T; Zhang XB; So CC; Yuen YP; Sun Q; Zhang C; Xu Y; Cheung JTK; Ng WH; Tang PM; Kang W; To KF; Lee WYW; Wong RSM; Poon ENY; Zhao Q; Huang J; Chen C; Yuen PMP; Li CK; Leung AWK; Leung KT
    Blood Cancer Discov; 2022 Nov; 3(6):516-535. PubMed ID: 35960210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RNA sequencing-based identification of potential targets in acute myeloid leukemia: A case report.
    El-Masry OS; Al-Amri AM; Alqatari A; Alsamman K
    Biomed Rep; 2020 Nov; 13(5):42. PubMed ID: 32934815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer.
    Newton Y; Rassekh SR; Deyell RJ; Shen Y; Jones MR; Dunham C; Yip S; Leelakumari S; Zhu J; McColl D; Swatloski T; Salama SR; Ng T; Hendson G; Lee AF; Ma Y; Moore R; Mungall AJ; Haussler D; Stuart JM; Jantzen C; Laskin J; Jones SJM; Marra MA; Morozova O
    JCO Precis Oncol; 2018; 2():. PubMed ID: 31372595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strong concordance between RNA structural and single nucleotide variants identified via next generation sequencing techniques in primary pediatric leukemia and patient-derived xenograft samples.
    Barwe SP; Gopalakrisnapillai A; Mahajan N; Druley TE; Kolb EA; Crowgey EL
    Genomics Inform; 2020 Mar; 18(1):e6. PubMed ID: 32224839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Corrigendum: Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention.
    Mercher T; Schwaller J
    Front Pediatr; 2019; 7():466. PubMed ID: 31788463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utilization of Genomic Tumor Profiling in Pediatric Liquid Tumors: A Clinical Series.
    Sharma I; Son MJ; Motamedi S; Hoeft A; Teller C; Hamby T; Ray A
    Hematol Rep; 2023 Apr; 15(2):256-265. PubMed ID: 37092520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single-cell genomic profiling of acute myeloid leukemia for clinical use: A pilot study.
    Yan B; Hu Y; Ban KHK; Tiang Z; Ng C; Lee J; Tan W; Chiu L; Tan TW; Seah E; Ng CH; Chng WJ; Foo R
    Oncol Lett; 2017 Mar; 13(3):1625-1630. PubMed ID: 28454300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor Genomic Profiling and
    Eaton A; Wong V; Schiff D; Anderson E; Ding H; Capparelli EV; Determan D; Kuo DJ
    J Pediatr Pharmacol Ther; 2022; 27(2):123-131. PubMed ID: 35241983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Corrigendum to "Prevalence of germline predisposition gene mutations in pediatric acute myeloid leukemia: Genetic background of pediatric AML" [Leuk. Res. 85 (2019) (October) 106210].
    Jeong D; Lee DS; Kim N; Choi S; Kim K; Kim SM; Im K; Park HS; Yun J; Lim KM; Park KS; Kang HJ; Ahn YO; Hwang SM
    Leuk Res; 2019 Dec; 87():106249. PubMed ID: 31666185
    [No Abstract]   [Full Text] [Related]  

  • 51. Erratum: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.
    Bolouri H; Farrar JE; Triche T; Ries RE; Lim EL; Alonzo TA; Ma Y; Moore R; Mungall AJ; Marra MA; Zhang J; Ma X; Liu Y; Liu Y; Auvil JMG; Davidsen TM; Gesuwan P; Hermida LC; Salhia B; Capone S; Ramsingh G; Zwaan CM; Noort S; Piccolo SR; Kolb EA; Gamis AS; Smith MA; Gerhard DS; Meshinchi S
    Nat Med; 2018 Apr; 24(4):526. PubMed ID: 29634680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia.
    Behrens YL; Gaschler L; Nienhold R; Reinkens T; Schirmer E; Knöß S; Strasser R; Sembill S; Wotschofsky Z; Suttorp M; Krumbholz M; Schlegelberger B; Metzler M; Göhring G; Karow A
    Haematologica; 2024 Mar; 109(3):942-947. PubMed ID: 37706343
    [No Abstract]   [Full Text] [Related]  

  • 53. Author Correction: A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing.
    Petti AA; Williams SR; Miller CA; Fiddes IT; Srivatsan SN; Chen DY; Fronick CC; Fulton RS; Church DM; Ley TJ
    Nat Commun; 2022 Jul; 13(1):4216. PubMed ID: 35864110
    [No Abstract]   [Full Text] [Related]  

  • 54. No small matter: qualitatively distinct challenges of pediatric genomic studies.
    Kohane IS
    Genome Med; 2011 Sep; 3(9):62. PubMed ID: 21961648
    [No Abstract]   [Full Text] [Related]  

  • 55. Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia.
    Laverdière I; Boileau M; Neumann AL; Frison H; Mitchell A; Ng SWK; Wang JCY; Minden MD; Eppert K
    Blood Cancer J; 2018 Jun; 8(6):52. PubMed ID: 29921955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older.
    Prassek VV; Rothenberg-Thurley M; Sauerland MC; Herold T; Janke H; Ksienzyk B; Konstandin NP; Goerlich D; Krug U; Faldum A; Berdel WE; Wörmann B; Braess J; Schneider S; Subklewe M; Bohlander SK; Hiddemann W; Spiekermann K; Metzeler KH
    Haematologica; 2018 Nov; 103(11):1853-1861. PubMed ID: 29903761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.
    Tarlock K; Liu X; Minard CG; Isikwei EA; Reid JM; Horton TM; Fox E; Weigel BJ; Cooper T
    Pediatr Blood Cancer; 2023 Dec; 70(12):e30672. PubMed ID: 37710306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.
    Johnson SM; Haberberger J; Galeotti J; Ramkissoon L; Coombs CC; Richardson DR; Foster MC; Duncan D; Zeidner JF; Ferguson NL; Montgomery ND
    Blood Cancer J; 2023 Jun; 13(1):96. PubMed ID: 37365170
    [No Abstract]   [Full Text] [Related]  

  • 59. Novel
    Tembrink M; Gerding WM; Wieczorek S; Mika T; Schroers R; Nguyen HP; Vangala DB; Nilius-Eliliwi V
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Next-Generation Sequencing-Based Genomic Profiling of Children with Acute Myeloid Leukemia.
    Krizsán S; Péterffy B; Egyed B; Nagy T; Sebestyén E; Hegyi LL; Jakab Z; Erdélyi DJ; Müller J; Péter G; Csanádi K; Kállay K; Kriván G; Barna G; Bedics G; Haltrich I; Ottóffy G; Csernus K; Vojcek Á; Tiszlavicz LG; Gábor KM; Kelemen Á; Hauser P; Gaál Z; Szegedi I; Ujfalusi A; Kajtár B; Kiss C; Matolcsy A; Tímár B; Kovács G; Alpár D; Bödör C
    J Mol Diagn; 2023 Aug; 25(8):555-568. PubMed ID: 37088137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.